FDA Provides PDUFA Target Agency Action Date For GTx’s Toremifene 80 mg NDA
MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI), today announced that the United States Food and Drug Administr READ MORE http://www.businesswire.com/portal/site/google/...